Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06159647 · ClinicalTrials.gov registry record · NA
Consumer Responses to Alcohol Warnings
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 2,522
- Enrollment target
NCT06159647: Completed NA study, sponsored by Stanford University.
NCT06159647 is a NA study that has completed, run by Stanford University. The registered enrollment target is 2,522 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06159647, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,522 participants
- Enrollment target
Study Summary
The primary objective is to evaluate whether alcohol warnings about different topics elicit higher perceived message effectiveness than control messages. The secondary objective is to evaluate whether alcohol warnings about different topics elicit higher reactance than control messages.
Interventions
- BEHAVIORAL Mouth cancer warning
- BEHAVIORAL Throat cancer warning
- BEHAVIORAL Voice box (larynx) warning
- BEHAVIORAL Esophagus cancer warning
- BEHAVIORAL Liver cancer warning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,522 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2024-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06159647
The ClinicalTrials.gov registry entry for NCT06159647 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,522 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Mouth cancer warning is the first listed.
NCT06159647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06159647 about?
NCT06159647 is a clinical study titled "Consumer Responses to Alcohol Warnings". The primary objective is to evaluate whether alcohol warnings about different topics elicit higher perceived message effectiveness than control messages. The secondary objective is to evaluate whether alcohol warnings about different topics elicit higher reactance than control messages.
What is the current status of trial NCT06159647?
This trial is currently completed. It is a NA study. The enrollment target is 2,522 participants. The study started on 2024-01-18. Estimated completion is 2024-01-26.
What interventions are being tested in trial NCT06159647?
The interventions under investigation include: Mouth cancer warning (BEHAVIORAL), Throat cancer warning (BEHAVIORAL), Voice box (larynx) warning (BEHAVIORAL), Esophagus cancer warning (BEHAVIORAL), Liver cancer warning (BEHAVIORAL).
Who is sponsoring clinical trial NCT06159647?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.